RA CAPITAL MANAGEMENT, L.P. - 08 Nov 2022 Form 3 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role: Director
Signature: /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol: SPRY
Transactions as of: 08 Nov 2022
Net transactions value: $0
Form type: 3
Filing time: 10 Nov 2022, 16:00:37 UTC
Previous filing: 24 Oct 2022
Next filing: 09 Nov 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Dr. Peter Kolchinsky, a Managing Partner of RA Capital Management, L.P., serves on the Issuer's board of directors.